Gilead Sciences GILD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.22B+54.5% | $8.51B+1,673% | $8.11B+7,014% | $6.31B+511% | $5.97B+1,202% | ||
| $903M+5.4% | $894M+7.1% | $886M+8.8% | $872M+9.0% | $857M+8.8% | ||
| $10.81B+4.2% | $10.02B-7.5% | $9.67B-3.5% | $9.87B+32.1% | $10.37B+22.2% | ||
| $576M+10.3% | $563M+7.6% | $505M-14.6% | $499M-12.8% | $522M-10.2% | ||
| $906M-15.3% | $1.07B-77.9% | $536M-89.4% | $939M-79.4% | $1.07B-77.0% | ||
| -$2.61B-57.4% | -$4.79B-39.0% | -$3.18B+19.4% | -$3.47B+0.1% | -$1.66B+54.6% | ||
| $4.03B+2.4% | $4B+2.2% | $3.98B+2.4% | $3.96B+2.6% | $3.94B+2.8% | ||
| $1.61B+8.9% | $1.92B+67.1% | $2.04B+115% | $1.91B+101% | $1.48B+48.0% | ||
| -$8.56B— | -$7.75B— | —— | —— | —— | ||
| —— | —— | —— | $2.37B+181% | $3.21B+1,572% | ||
| $10.23B+3.9% | $9.46B-8.2% | $9.16B-2.9% | $9.37B+35.9% | $9.84B+24.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gilead Sciences generate?
- Gilead Sciences (GILD) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Gilead Sciences's free cash flow?
- After $576.0M of capital expenditures, Gilead Sciences's free cash flow was $10.2B over the trailing twelve months, up 3.9% year over year.
- Where does Gilead Sciences's cash flow data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
